Cardiac effects of halofantrine in children suffering from acute uncomplicated falciparum malaria

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 4, 1998, Pages 446-448

  Sowunmi, A ^a,d   Falade, C O ^a   Oduola, A M J ^a   Ogundahunsi, O A T ^a   Fehintola, F A ^a   Gbotosho, G O ^a   Larcier, P ^b   Salako, L A ^a,c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b SB Laboratoire Pharmaceutique   (France)

^c NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Cardiotoxicity; Chemotherapy; Children; Halofantrine; Malaria; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; HALOFANTRINE;

ADOLESCENT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART ARRHYTHMIA; HUMAN; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PR INTERVAL; QT INTERVAL;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031709017     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)91086-0     Document Type: Article

References (22)

1. Abu-Aisha, H., Abu-Sabaa, H. M. A. & Nur, T. (1979). Cardiac arrest after intravenous chloroquine injection. Journal of Tropical Medicine and Hygiene, 82, 36-37.
2. Bazett, H. C. (1920). An analysis of time relations of electrocardiograms. Heart, 7, 353-370.
3. Boudreau, E. R, Pang, L. W., Dixon, K. E., Webster, H. K., Pavanand, K., Tosingha, L., Somutsakorn, P. & Canfield, C. J. (1988). Malaria: treatment efficacy of halofantrine in initial field trials in Thailand. Bulletin of the World Health Organization, 65, 227-235.
4. Castot, A., Rapoport, P. & Le Coz, P. (1993). Prolonged QT interval with halofantrine. Lancet, 341, 1541.
5. CDC &WHO (1994). Epi-Info Version 6. A word processing database and statistics program for public health on IBM-compatible microcomputer. Atlanta: Centers for Disease Control and Prevention & Geneva: World Health Organization.
6. Falade, C. O., Salako, L. A., Sowunmi, A., Oduola, A. M. J. & Larcier, P. (1997). Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 58-62.
7. Garson, A. (1983). The Electrocardiogram in Infants and Children: A Systematic Approach. Philadelphia: Lea & Febiger.
8. Greenwood, B. M., Bradley, A. K., Greenwood, A. M., Byass, P., Jammeh, K., Marsh, K.,Tulloch, S., Oldfield, F. S. J. & Hayes, R. (1987). Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 81, 478-486.
9. Hien, T. T. & White, N. J. (1993). Quinghaosu. Lancet, 341, 603-608.
10. Karbwang, J., Na Bangchang, K., Bunnag, D. & Harinasuta, T. (1993). Cardiac effects of halofantrine. Lancet, 342, 501.
11. Monlun, E., Pillet, O., Cochard, J. F., Favarel-Guarrigues, J. Cl. & Le Bras, M. (1993). Prolonged QT interval with halofantrine. Lancet, 341, 1541-1542.
12. Monlun, E., Le Metayer, P., Szwandt, S., Neau, D., Longy-Boursier, M. & Horton, J. (1995). Cardiac complications of halofantrine: a prospective study of 20 patients. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 430-433.
13. Nosten, F, Ter Kuile, F. O., Luxemburger, C.,Woodrow, C., Kyle, D. E., Chonsuphajaisiddhi, T. & White, N. J. (1993). Cardiac effects of antimalarial treatment with halofantrine. Lancet, 341, 1054-1056.
14. Olatunde, I. A. (1970). Parenteral chloroquine in children. West African Medical Journal, 19, 93-99.
15. Park, M. K. & Guntheroth,W. G. (1992). How to Read Pediatric ECGs. St Louis: Mosby-Year Book.
16. Salako, L. A., Sowunmi, A. & Walker, O. (1990). Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 644-647.
17. Seidlein, L. von, Jaffar, S. & Greenwood, B. (1997). Prolongation of the QTc interval in African children treated for falciparum malaria. American Journal of Tropical Medicine and Hygiene, 56, 494-497.
18. Touze, J. E., Bernard, J., Keundjian, A., Imbert, P., Viguier, A., Chaudet, H. & Doury, J. C. (1996). Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria. American Journal of Tropical Medicine and Hygiene, 54, 225-228.
19. Warrell, D. A., Molyneux, M. E. & Beales, P. F. (editors) (1990). Severe and complicated malaria, 2nd edition. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, supplement 2.
20. Watkins, W. M., Oloo, J. A., Lury, J. D., Mosoba, M., Kariuki, D., Mjomba, M., Koech, D. K. & Gilles, H. M. (1988). Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya. Lancet, ii, 247-249.
21. White, N. J., Looaresuwan, S. & Warrell, D. A. (1983). Quinine and quinidine: a comparison of EKG effects during the treatment of malaria. Journal of Cardiovascular Pharmacology, 5, 173-175.
22. Wirima, J., Khoromana, C., Molyneux, M. E. & Gilles, H. M. (1988). Clinical trials with halofantrine hydrochloride in Malawi. Lancet, ii, 250-253.